Correction: Primary cold atmospheric plasma combined with low dose cisplatin as a possible adjuvant combination therapy for HNSCC cells—an in‑vitro study

Detalles Bibliográficos
Autores principales: Brunner, Teresa F., Probst, Florian A., Troeltzsch, Matthias, Schwenk‑Zieger, Sabina, Zimmermann, Julia L., Morfill, Gregor, Becker, Sven, Harréus, Ulrich, Welz, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436649/
https://www.ncbi.nlm.nih.gov/pubmed/37596585
http://dx.doi.org/10.1186/s13005-023-00386-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436649/
https://www.ncbi.nlm.nih.gov/pubmed/37596585
http://dx.doi.org/10.1186/s13005-023-00386-x

Ejemplares similares